FDA Approves Transplant Trials for Gene-Edited Pig Kidneys
The FDA will allow two biotechnology companies to run clinical trials: United Therapeutics and eGenesis. United Therapeutics Corporation will start with six patients but could grow its trial to include up to 50 individuals, while eGenesis plans to begin with three patients.
FDA Approves Clinical Trials for Pig Kidney Transplants in Humans
HealthDay News — The US Food and Drug Administration (FDA) has approved the first-ever clinical trials testing pig kidney transplants in people with kidney failure, marking a major step forward in cross-species transplantation.
FDA approves pig organ transplant trials for patients with kidney failure
The first clinical trials using organs from genetically modified pigs offer hope to patients with kidney failure, who face a long wait for human organ transplants.
United Therapeutics scores FDA go-ahead for pig organ transplant clinical trial
Silver Spring’s United Therapeutics has scored a regulatory green light to start clinical trials for its genetically modified pig kidneys to be transplanted into humans. It's as significant for the medical community as it is for the business.
F.D.A. Approves Studies of Pig Organ Transplants for Kidney Patients
The research offers hope to tens of thousands of patients with kidney failure who are on a long waiting list for an organ transplant.
United Therapeutics Says FDA Clears IND For The UKidney Xenotransplantation Clinical Trial
United Therapeutics Corp. (UTHR), a public benefit corporation, announced Monday that the U.S. Food and Drug Administration (FDA) has
FDA Greenlights Studies of Pig Kidney Transplants in Humans
The US Food and Drug Administration approved clinical trials that will transplant organs from genetically modified pigs into patients with kidney failure.
Breakthrough: US FDA clears first gene-edited pig kidney transplants in humans
In a significant development for organ transplantation, two U.S. biotechnology companies, United Therapeutics and
United Therapeutics president sells $3.5m in stock
Michael Benkowitz, President and COO of United Therapeutics Corp (NASDAQ:UTHR), recently executed a series of stock transactions, according to a recent SEC filing. On February 3, Benkowitz sold shares ...
Seeking Alpha8d
UTHR United Therapeutics Corporation
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life ...